Immuno-Genic Corp

Immune Modulation Therapy and Research Since 1999, and the Nobel Prize winning discovery that Nitric Oxide is a primary signaling molecule, the regulated generation and modulation of Nitric Oxide (without inducing toxicity) in mammalian cells has bee...

Immune Modulation Therapy and Research Since 1999, and the Nobel Prize winning discovery that Nitric Oxide is a primary signaling molecule, the regulated generation and modulation of Nitric Oxide (without inducing toxicity) in mammalian cells has been at the center of an intense research effort currently being conducted worldwide by thousands of research scientists and hundreds of research facilities and institutions. The evasive knowledge of how to and/or the means by which Nitric Oxide control could be accomplished has eluded discovery, even after years of research by some of the best minds in the scientific community. Now, with Immuno-Genic Corporation's Ig2000 Technology, this question, whose elusive answer has long been awaited, is answered.